Login / Signup

Discovery of an alternative pathway of peptidoglycan biosynthesis: A new target for pathway specific inhibitors.

Yasushi OgasawaraTohru Dairi
Published in: Journal of industrial microbiology & biotechnology (2021)
Peptidoglycan in bacterial cell walls is a biopolymer consisting of sugars and amino acids and plays important role in maintaining cell integrity from the environment. Its biosynthesis is a major target for antibiotics and the genes and enzymes involved in the biosynthetic pathway have been well studied. However, we recently identified an alternative pathway in the early stage of peptidoglycan biosynthesis in Xanthomonas oryzae, a plant pathogen causing bacterial blight disease of rice. The distribution of the alternative pathway is limited to relatively few bacterial genera that contain many pathogenic species, including Xylella and Stenotrophomonas, besides Xanthomonas. Thus, the alternative pathway is an attractive target for the development of narrow spectrum antibiotics specific to pathogens. In this minireview, we summarize the discovery of the alternative pathway and identification of its specific inhibitors.
Keyphrases
  • early stage
  • cell wall
  • squamous cell carcinoma
  • stem cells
  • gene expression
  • amino acid
  • radiation therapy
  • bone marrow
  • genome wide
  • dna methylation
  • candida albicans
  • rectal cancer
  • bacillus subtilis